Christian Schütz

Title: Christian Schütz: Innovator in Pharmaceutical Research

Introduction

Christian Schütz is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target bacterial infections.

Latest Patents

Christian Schütz holds a patent for PqsR inverse agonists. This invention relates to a compound that acts as an inhibitor of PqsR, the only known receptor for the Quinolone Signal (PQS). The patent includes a pharmaceutical composition containing one or more of the compounds of the invention, as well as a combination preparation that includes at least one compound of the invention and at least one further active pharmaceutical ingredient. The uses of these compounds include their application as a medicament, particularly in the treatment or prophylaxis of bacterial infections.

Career Highlights

Christian Schütz is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he conducts research and development in the field of infectious diseases. His work has been instrumental in advancing the understanding of bacterial infections and developing new therapeutic strategies.

Collaborations

Christian collaborates with several esteemed colleagues, including Ahmed S A Ahmed and Martin Empting. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Christian Schütz is a prominent figure in pharmaceutical innovation, with a focus on combating bacterial infections through his patented research. His contributions are vital to the ongoing efforts in medical science.